IP Library Granted Patent US 8,701,656
Granted Patent B2
US 8,701,656 · App. 12/990,550 · Granted Apr 22, 2014

Inhaler

Inventors: Markus Kaemper (Breckerfeld, DE); Jens Besseler (Bingen am Rhein, DE)
Assignee: Boehringer Ingelheim International GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,701,656
App. No.
12/990,550
Granted
Apr 22, 2014
Kind
B2
Abstract

An inhaler ( 1 ) is proposed for delivering a preferably powdered formulation from a blister strip ( 3 ) having a plurality of blister pockets ( 4 ). The inhaler comprises a life span blocking device ( 31 ) which blocks opening of a cover ( 15 ) of the inhaler in a blocking state by means of locking element ( 39 ) interlocking the cover with a housing ( 19 ) of the inhaler.

Claims (22)

1. An inhaler ( 1 ) for discharging a powdered formulation ( 2 ) in multiple doses one after the other,

with an outlet or mouthpiece ( 7 ) for discharging a nebulized or atomized formulation ( 2 ),

with a cover ( 15 ) moveable between a closed position covering the outlet or mouthpiece ( 7 ), and an open position uncovering the outlet or mouthpiece ( 7 ),

with a life span blocking device ( 31 ) for blocking further use or operation of the inhaler ( 1 ) in a blocking state, when operation or use of the inhaler ( 1 ) reaches or exceeds a predetermined number of operations or uses,

wherein the life span blocking device ( 31 ) blocks movement or opening of the cover ( 15 ) in the blocking state, and

wherein the life span blocking device ( 31 ) comprises a control member ( 35 ) and a control wheel ( 32 ) rotatable relative to the control member ( 35 ), wherein the control wheel ( 32 ) and/or the control member ( 35 ) comprise keying means so that axial movement of the control member ( 35 ) relative to the control wheel ( 32 ) is possible only in one rotational position of the control wheel ( 32 ) relative to the control member ( 35 ) to release a locking element ( 39 ).

2. The inhaler according to claim 1 , characterized in that the inhaler ( 1 ) is constructed such that the cover ( 15 ) can be closed in the blocking state.

3. The inhaler according to claim 1 , characterized in that the life span blocking device ( 31 ) comprises a locking element ( 39 ) interlocking in the interlocking position the cover ( 15 ) with a housing ( 19 ) or another stationary component of the inhaler ( 1 ).

4. The inhaler according to claim 3 , characterized in that the locking element ( 39 ) is biased into the interlocking position by spring force.

5. The inhaler according to claim 3 , characterized in that the locking element ( 39 ) is held in a non-interlocking position and released or forced into the interlocking position in the blocking state.

6. An inhaler ( 1 ) for delivering a powdered formulation ( 2 ) in multiple doses one after the other,

with a life span blocking device ( 31 ) for blocking further use or operation of the inhaler ( 1 ) in a blocking state, when operation or use of the inhaler ( 1 ) reaches or exceeds a predetermined number of operations or uses,

wherein the life span blocking device ( 31 ) comprises a locking element ( 39 ) which is biased into an interlocking position for blocking further use or operation of the inhaler ( 1 ),

wherein the locking element ( 39 ) is held in a non-interlocking position and released or forced into the interlocking position in the blocking state, and

wherein the life span blocking device ( 31 ) comprises a control member ( 35 ) and a control wheel ( 32 ) rotatable relative to the control member ( 35 ), wherein the control wheel ( 32 ) and/or the control member ( 35 ) comprise keying means so that axial movement of the control member ( 35 ) relative to the control wheel ( 32 ) is possible only in one rotational position of the control wheel ( 32 ) relative to the control member ( 35 ) to release the locking element ( 39 ).

7. The inhaler according to claim 6 , characterized in that the control member ( 35 ) is interconnected with or forming the locking element ( 39 ), and/or that the control member ( 35 ) is biased axially by means of a spring ( 42 ), acting between the control wheel ( 32 ) and the control member ( 35 ), wherein the spring ( 42 ) biases the locking element ( 39 ) into or in the interlocking position.

8. The inhaler according to claim 6 , characterized in that the control wheel ( 32 ) is actuated by gear reduction stepwise by an element ( 25 ).

9. The inhaler according to claim 1 , characterized in that the inhaler ( 1 ) comprises a blister strip ( 3 ), with a plurality of blister pockets ( 4 ), containing the formulation ( 2 ) in doses.

10. The inhaler according to claim 9 , characterized in that the inhaler ( 1 ) comprises a conveying device ( 5 ) for moving stepwise onward the blister strip.

11. The inhaler according to claim 10 , characterized in that the conveying device ( 5 ) or an associated transmission ( 21 ) drives the life span blocking device ( 31 ).

12. The inhaler according to claim 10 , characterized in that the conveying device ( 5 ) or an associated transmission ( 21 ) is driven by opening and/or closing of the cover ( 15 ).

13. The inhaler according to claim 6 , characterized in that the inhaler ( 1 ) comprises a blister strip ( 3 ) with a plurality of blister pockets ( 4 ) containing the formulation ( 2 ) in doses and a conveying device ( 5 ) for moving stepwise onward the blister strip ( 3 ), wherein the conveying device ( 5 ) or an associated transmission ( 21 ) drives the control wheel ( 32 ).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2010
From: KAEMPER, MARKUS; BESSELER, JENS
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 025431/0012 →
Priority Claims (1)
EP 08008332 · May 2, 2008 · regional
Continuity (1)
Related Publication 20110126827A1 · Jun 2, 2011